Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy

Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy

This study aimed to investigate the impact of indoleamine 2,3-dioxygenase 1 (IDO1) expression, programmed cell death-ligand 1 (PD-L1) expression, CD8+ tumor-infiltrating lymphocyte (TIL) status, and their combination on pathologic complete response (pCR) and recurrence in esophageal squamous cell ca...

Full description

Bibliographic Details
Main Authors: Sha Zhou, Lei Zhao, Zhaohui Liang, Songran Liu, Yong Li, Shiliang Liu, Hong Yang, Mengzhong Liu, Mian Xi
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Cancers
Subjects:
esophageal squamous cell carcinoma
neoadjuvant chemoradiotherapy
IDO1
PD-L1
pathologic response
Online Access:https://www.mdpi.com/2072-6694/11/2/169

Internet

https://www.mdpi.com/2072-6694/11/2/169

Similar Items